Kwality Pharmaceuticals Limited (BOM:539997)
India
· Delayed Price · Currency is INR 933.60
-16.60 (-1.75%)
At close: May 27, 2025
Kwality Pharmaceuticals Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| Cash & Equivalents | 147.55 | 22.58 | 30.7 | 91.35 | 58.09 | Upgrade
|
| Short-Term Investments | - | 36.86 | 42.94 | 38.16 | 44.38 | Upgrade
|
| Cash & Short-Term Investments | 147.55 | 59.44 | 73.63 | 129.51 | 102.46 | Upgrade
|
| Cash Growth | 148.25% | -19.28% | -43.14% | 26.40% | 110.14% | Upgrade
|
| Accounts Receivable | 1,543 | 1,144 | 716.94 | 691.31 | 357.11 | Upgrade
|
| Other Receivables | - | 163.82 | 68.96 | 88.01 | - | Upgrade
|
| Receivables | 1,543 | 1,308 | 785.91 | 779.32 | 357.11 | Upgrade
|
| Inventory | 834.66 | 783.87 | 863.15 | 533.6 | 307.84 | Upgrade
|
| Prepaid Expenses | - | - | - | - | 0.9 | Upgrade
|
| Other Current Assets | 312.51 | 275.9 | 349.31 | 835.76 | 290.69 | Upgrade
|
| Total Current Assets | 2,838 | 2,427 | 2,072 | 2,278 | 1,059 | Upgrade
|
| Property, Plant & Equipment | 1,440 | 1,391 | 1,348 | 1,039 | 594.21 | Upgrade
|
| Long-Term Investments | - | - | 9.32 | 7.82 | 0.56 | Upgrade
|
| Other Intangible Assets | 17.07 | - | - | - | - | Upgrade
|
| Long-Term Deferred Tax Assets | 16.15 | 0.25 | - | - | 0.38 | Upgrade
|
| Other Long-Term Assets | 161.88 | 124.4 | 107.12 | 81.08 | 8.5 | Upgrade
|
| Total Assets | 4,473 | 3,942 | 3,536 | 3,406 | 1,663 | Upgrade
|
| Accounts Payable | 557.93 | 443.17 | 351.92 | 345.15 | 262.15 | Upgrade
|
| Accrued Expenses | - | 25.4 | 8.48 | 5.58 | 19.61 | Upgrade
|
| Short-Term Debt | 973.26 | 785.59 | 629.61 | 337.23 | 164.55 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | 91.8 | 65.09 | Upgrade
|
| Current Income Taxes Payable | 59.31 | 65.21 | 64.84 | 410 | 58 | Upgrade
|
| Other Current Liabilities | 104.55 | 199.13 | 204.6 | 205.1 | 213.51 | Upgrade
|
| Total Current Liabilities | 1,695 | 1,519 | 1,259 | 1,395 | 782.91 | Upgrade
|
| Long-Term Debt | 151.19 | 195.6 | 273.03 | 202.88 | 182.64 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | - | 4.11 | 2.75 | - | Upgrade
|
| Other Long-Term Liabilities | 0 | - | - | - | 91.8 | Upgrade
|
| Total Liabilities | 1,849 | 1,716 | 1,546 | 1,608 | 1,064 | Upgrade
|
| Common Stock | 103.76 | 103.76 | 103.76 | 103.76 | 103.76 | Upgrade
|
| Additional Paid-In Capital | - | 84.68 | 84.68 | - | 84.68 | Upgrade
|
| Retained Earnings | - | 2,046 | 1,809 | 1,700 | 414.27 | Upgrade
|
| Comprehensive Income & Other | 2,537 | 7.63 | 8 | 8.04 | 8.82 | Upgrade
|
| Total Common Equity | 2,640 | 2,242 | 2,005 | 1,811 | 611.53 | Upgrade
|
| Minority Interest | -16.52 | -16.28 | -14.47 | -13.55 | -13.02 | Upgrade
|
| Shareholders' Equity | 2,624 | 2,226 | 1,991 | 1,798 | 598.51 | Upgrade
|
| Total Liabilities & Equity | 4,473 | 3,942 | 3,536 | 3,406 | 1,663 | Upgrade
|
| Total Debt | 1,124 | 981.19 | 902.64 | 631.92 | 412.28 | Upgrade
|
| Net Cash (Debt) | -976.9 | -921.75 | -829 | -502.41 | -309.82 | Upgrade
|
| Net Cash Per Share | -94.05 | -88.83 | -79.89 | -48.42 | -29.86 | Upgrade
|
| Filing Date Shares Outstanding | 10.39 | 10.38 | 10.38 | 10.38 | 10.38 | Upgrade
|
| Total Common Shares Outstanding | 10.39 | 10.38 | 10.38 | 10.38 | 10.38 | Upgrade
|
| Working Capital | 1,143 | 908.39 | 812.54 | 883.33 | 276.09 | Upgrade
|
| Book Value Per Share | 254.23 | 216.08 | 193.25 | 174.58 | 58.94 | Upgrade
|
| Tangible Book Value | 2,623 | 2,242 | 2,005 | 1,811 | 611.53 | Upgrade
|
| Tangible Book Value Per Share | 252.58 | 216.08 | 193.25 | 174.58 | 58.94 | Upgrade
|
| Land | - | - | - | - | 10.58 | Upgrade
|
| Buildings | - | 514.35 | 281.53 | 228.11 | 214.88 | Upgrade
|
| Machinery | - | 1,363 | 1,272 | 966.75 | 582.46 | Upgrade
|
| Construction In Progress | - | - | 142.92 | 121.49 | 28.94 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.